In the fourth quarter of 2024, the global Ampicillin market witnessed a generally stable but slightly increasing price trend. Early in the quarter, the market was characterized by weak demand, particularly in regions like Asia, where sluggish consumption from key sectors limited market activity. This was compounded by rising freight costs, which affected supply chains and contributed to supply tightness. However, as the quarter progressed, prices began to rise due to improved demand in the pharmaceutical sector, especially in Europe and North America, as companies sought to replenish stockpiles in anticipation of potential supply disruptions. Logistical challenges, such as port congestion and rising shipping costs, continued to exert upward pressure on prices.
The European market, in particular, saw more significant price movements as companies adjusted their strategies to cope with supply chain difficulties and stockpiling efforts. Similarly, in North America, a strong recovery in consumer confidence contributed to increased buying activity, which further supported price increases in the later months.